Hyundai Pharmaceutical Co., Ltd.
004310.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$209.92B
Close$
$-7698.50
213.4% downside
Current Fair Value
213.4% downsideOvervalued by 213.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $209.92 Billion |
|---|---|
| Enterprise Value | $257.42 Billion |
| Dividend Yield | $30.00 (0.44%) |
| Earnings per Share | $96.28 |
| Beta | 0.7 |
| Outstanding Shares | 30,916,352 |
Return
| Return on Equity | 2.82% |
|---|---|
| Return on Assets | 1.61% |
| Return on Invested Capital | 3.43% |
Valuation & Multiples
| P/E Ratio | 56.19 |
|---|---|
| PEG | -171.62 |
| Price to Sales | 1.01 |
| Price to Book Ratio | 1.64 |
| Enterprise Value to Revenue | 1.24 |
| Enterprise Value to EBIT | 46.67 |
| Enterprise Value to Net Income | 71 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 0.43 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Hyundai Pharmaceutical Co., Ltd.
399 employees
CEO: Sang-Jun Lee Headquartered in Seoul, South Korea, Hyundai Pharmaceutical Co., Ltd. is an international manufacturer and distributor of a diverse portfolio that includes pharmaceutical products, health food beverages, and medical equipment. The compan...